Podcast Episodes
Back to Search397: A pancreatic cancer breakthrough, and new hope for an off-the-shelf CAR-T treatment
On this week’s episode of the Readout LOUD: a pancreatic cancer breakthrough and new hope for an off-the-shelf CAR-T treatment in lymphoma.
Your favo…
6 months ago
396: A new trick for old science, and biotech VCs' scrambled playbook
Why is old exon science getting new traction? What’s unsettling biotech VCs? And who will be the next CEO of PhRMA?
Adam is out, so Elaine and Alliso…
6 months, 1 week ago
395: Biotech investors' plea to Trump, and a busy M&A week
How has the Food and Drug Administration's recent decisions on rare disease drugs affected investment trends? Why is Eli Lilly getting into sleep med…
6 months, 2 weeks ago
394: Eli Lilly's deal man, Allogene's off-the-shelf CAR-T, and Merck's Terns buy
On this week’s episode of "The Readout LOUD": Allison DeAngelis is still away, leaving Elaine Chen and Adam Feuerstein to mind the podcasting store. …
6 months, 3 weeks ago
393: A conversation with the 'godfather' of biotech
On this week's episode of "The Readout LOUD," we bring you a special conversation with Stelios Papadapolous, also know as the "godfather" of biotech.…
6 months, 3 weeks ago
392: Epstein's pal attempts a biotech comeback, and Prasad exits the FDA
How was a known friend of Jeffrey Epstein able to raise $100 million, with the help of a prominent biotech VC? And will Vinay Prasad return to the Fo…
7 months ago
391: Breaching the IBD efficacy ceiling, and sham surgeries
Will drugmakers finally be able to breach the efficacy ceiling in inflammatory bowel disease? And is the Food and Drug Administration being flexible …
7 months, 1 week ago
390: FDA turmoil, election intrigue, AI, and more
On "The Readout LOUD" this week: Adam Feuerstein, solo. His usual co-hosts Allison DeAngelis and Elaine Chen took some time off, so Adam manned the p…
7 months, 3 weeks ago
389: Hims' Super Bowl fallout, and the FDA reverses course
Was Hims' Super Bowl ad the final straw for regulators? Is the bar being lowered for psychedelic medicines? And what's happening behind-the-scenes wi…
7 months, 4 weeks ago
388: The FDA's refusal to review Moderna's mRNA flu vaccine
We’re devoting our entire episode this week to one controversial and impactful topic: the FDA’s decision to block the review of Moderna’s mRNA flu sh…
8 months ago